| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1034520533 |
| P356 | DOI | 10.2165/00023210-200317060-00002 |
| P698 | PubMed publication ID | 12696999 |
| P50 | author | Hans-Jürgen Möller | Q1577771 |
| P2093 | author name string | Frank Padberg | |
| P2860 | cites work | Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine | Q24685198 |
| Right and left prefrontal transcranial magnetic stimulation at 1 Hz does not affect mood in healthy volunteers | Q24801274 | ||
| Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996 | Q28262619 | ||
| Is the forced swimming test a suitable model for revealing antidepressant activity? | Q28290947 | ||
| Prefrontal repetitive transcranial magnetic stimulation as add on treatment in depression | Q28354283 | ||
| The process of reinnervation in the dentate gyrus of adult rats: temporal relationship between changes in the levels of glial fibrillary acidic protein (GFAP) and GFAP mRNA in reactive astrocytes | Q30466894 | ||
| High frequency transcranial magnetic stimulation mimics the effects of ECS in upregulating astroglial gene expression in the murine CNS. | Q30470178 | ||
| Transcranial magnetic stimulation: applications in neuropsychiatry | Q30572921 | ||
| Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression | Q31833575 | ||
| Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy | Q31925061 | ||
| Transcranial magnetic stimulation induces alterations in brain monoamines | Q73458379 | ||
| Transcranial magnetic stimulation induces 'pseudoabsence seizure' | Q73559389 | ||
| Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain | Q73960235 | ||
| Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: an in vivo microdialysis study | Q74126285 | ||
| Acute mood and thyroid stimulating hormone effects of transcranial magnetic stimulation in major depression | Q74214628 | ||
| Transcranial magnetic stimulation in therapy studies: examination of the reliability of "standard" coil positioning by neuronavigation | Q74214652 | ||
| How coil-cortex distance relates to age, motor threshold, and antidepressant response to repetitive transcranial magnetic stimulation | Q74218906 | ||
| A controlled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly | Q74337329 | ||
| Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology | Q77354244 | ||
| Methodological aspects in the assessment of severity of depression by the Hamilton Depression Scale | Q77587884 | ||
| Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial | Q77946849 | ||
| Repetitive transcranial magnetic stimulation induces active coping strategies and attenuates the neuroendocrine stress response in rats. | Q51072443 | ||
| Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. | Q51120793 | ||
| Magnetic seizure therapy of major depression. | Q51362951 | ||
| Lack of adverse cognitive effects of 1 Hz and 20 Hz repetitive transcranial magnetic stimulation at 100% of motor threshold over left prefrontal cortex in depression. | Q51961708 | ||
| Left prefrontal activation predicts therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) in major depression. | Q51972399 | ||
| Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. | Q52012874 | ||
| Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS. | Q52030036 | ||
| Bupropion in depression. I. Biochemical effects and clinical response. | Q52087404 | ||
| Are placebo controls necessary to test new antidepressants and anxiolytics? | Q52944433 | ||
| Which patients with major depression benefit from prefrontal repetitive magnetic stimulation | Q53886456 | ||
| Sleep deprivation combined with consecutive sleep phase advance as a fast-acting therapy in depression: an open pilot trial in medicated and unmedicated patients. | Q53969159 | ||
| A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. | Q54061742 | ||
| A controlled trial of daily left prefrontal cortex TMS for treating depression | Q57258434 | ||
| Interactions of amineptine with the neuronal dopamine uptake system: Neurochemicalin vitro andin vivo studies | Q59665171 | ||
| Comparison of unlimited numbers of rapid transcranial magnetic stimulation (rTMS) and ECT treatment sessions in major depressive episode | Q60697124 | ||
| Substitution of rapid transcranial magnetic stimulation treatments for electroconvulsive therapy treatments in a course of electroconvulsive therapy | Q60697127 | ||
| Dexamethasone Suppression Test Reversal in Rapid Transcranial Magnetic Stimulation-Treated Depression | Q60697129 | ||
| Rapid transcranial magnetic stimulation and normalization of the dexamethasone suppression test | Q60697131 | ||
| The effect of transcranial magnetic stimulation of rat brain on behavioral models of depression | Q71046297 | ||
| Dopamine and depression | Q72222122 | ||
| Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide | Q72520154 | ||
| Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain | Q73072489 | ||
| Changes in mood and hormone levels after rapid-rate transcranial magnetic stimulation (rTMS) of the prefrontal cortex | Q73178289 | ||
| Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS | Q73203002 | ||
| Transcranial magnetic stimulation: a novel antidepressive strategy? | Q73274684 | ||
| Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism | Q73331945 | ||
| Neuroendocrine and behavioral effects of repetitive transcranial magnetic stimulation in a psychopathological animal model are suggestive of antidepressant-like effects | Q31969325 | ||
| How should efficacy be evaluated in randomized clinical trials of treatments for depression? | Q33543677 | ||
| Repetitive transcranial magnetic stimulation as a neuropsychiatric tool: present status and future potential. | Q33585956 | ||
| Transcranial magnetic stimulation (TMS) in controlled treatment studies: are some "sham" forms active? | Q33891107 | ||
| Sham TMS: intracerebral measurement of the induced electrical field and the induction of motor-evoked potentials | Q33940055 | ||
| Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome | Q33955717 | ||
| The functional neuroanatomy of the placebo effect | Q34126324 | ||
| Transcranial magnetic stimulation: applications in basic neuroscience and neuropsychopharmacology | Q34245200 | ||
| Therapeutic application of repetitive transcranial magnetic stimulation: a review | Q34311455 | ||
| Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms? | Q34385977 | ||
| Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses | Q34583670 | ||
| Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. | Q34677630 | ||
| Transcranial magnetic stimulation for treating depression | Q34699266 | ||
| Slow transcranial magnetic stimulation, long-term depotentiation, and brain hyperexcitability disorders | Q34714533 | ||
| Effects of antidepressant treatment on neuroactive steroids in major depression | Q34749115 | ||
| Role of the dopaminergic system in depression | Q35361084 | ||
| Thyrotropin-releasing hormone (TRH), the thyroid axis, and affective disorder | Q38224460 | ||
| Effects of a dopamine agonist piribedil in depressed patients: relationship of pretreatment homovanillic acid to antidepressant response | Q40195412 | ||
| Relation between responses to repetitive transcranial magnetic stimulation and partial sleep deprivation in major depression | Q40654652 | ||
| Cortico-cortical connectivity of the human mid-dorsolateral frontal cortex and its modulation by repetitive transcranial magnetic stimulation | Q40676613 | ||
| Mood effects of repetitive transcranial magnetic stimulation of left prefrontal cortex in healthy volunteers | Q40757883 | ||
| The use of rapid-rate transcranial magnetic stimulation (rTMS) in refractory depressed patients | Q40862975 | ||
| Antidepressants and hypothalamic-pituitary-adrenocortical regulation | Q41032512 | ||
| Transcranial magnetic stimulation: a tool for mapping the central nervous system | Q41373325 | ||
| Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex | Q41685658 | ||
| Effects of acute and chronic electroconvulsive shock on noradrenaline release in the rat hippocampus and frontal cortex | Q41816997 | ||
| Chronic repetitive transcranial magnetic stimulation induces subsensitivity of presynaptic serotonergic autoreceptor activity in rat brain | Q42493870 | ||
| Effects of left frontal transcranial magnetic stimulation on depressed mood, cognition, and corticomotor threshold | Q42603043 | ||
| Effects of a 2- to 4-week course of repetitive transcranial magnetic stimulation (rTMS) on neuropsychologic functioning, electroencephalogram, and auditory threshold in depressed patients | Q42647224 | ||
| Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates | Q43525714 | ||
| The transcranial magnetic stimulation motor threshold depends on the distance from coil to underlying cortex: a replication in healthy adults comparing two methods of assessing the distance to cortex | Q43556924 | ||
| SPECT mapping of cerebral activity changes induced by repetitive transcranial magnetic stimulation in depressed patients. A pilot study | Q43623882 | ||
| Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. | Q43680057 | ||
| Unilateral left prefrontal transcranial magnetic stimulation (TMS) produces intensity-dependent bilateral effects as measured by interleaved BOLD fMRI. | Q43796253 | ||
| Effect of chronic repetitive transcranial magnetic stimulation on regional cerebral blood flow and regional cerebral glucose uptake in drug treatment-resistant depressives. A brief report | Q43861681 | ||
| Prediction of clinical response to transcranial magnetic stimulation for depression by baseline lateral visual-field stimulation. | Q43904835 | ||
| Effects of different frequencies of transcranial magnetic stimulation (TMS) on the forced swim test model of depression in rats | Q43939719 | ||
| Occurrence of delusions during repetitive transcranial magnetic stimulation (rTMS) in major depression | Q43957440 | ||
| Non-invasive magnetic stimulation of human motor cortex | Q43998000 | ||
| Left prefrontal-repetitive transcranial magnetic stimulation (rTMS) and regional cerebral glucose metabolism in normal volunteers | Q44123501 | ||
| Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system | Q44126383 | ||
| Left dorso-lateral repetitive transcranial magnetic stimulation affects cortical excitability and functional connectivity, but does not impair cognition in major depression | Q44171283 | ||
| Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in major depression | Q44216557 | ||
| Chronic psychosocial stress and concomitant repetitive transcranial magnetic stimulation: effects on stress hormone levels and adult hippocampal neurogenesis. | Q44235501 | ||
| The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression | Q44306069 | ||
| A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression | Q44315065 | ||
| Reduction of prefrontal cortex glucose metabolism common to three types of depression | Q45097380 | ||
| Antidepressant effects of repetitive transcranial magnetic stimulation in the elderly: correlation between effect size and coil-cortex distance | Q47184435 | ||
| Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration | Q47962858 | ||
| Repetitive transcranial magnetic stimulation in rats: evidence for a neuroprotective effect in vitro and in vivo | Q48098617 | ||
| Electrical stimulation of rat medial prefrontal cortex enhances forebrain serotonin output: implications for electroconvulsive therapy and transcranial magnetic stimulation in depression | Q48130321 | ||
| Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain | Q48148658 | ||
| Induction of a reversible state of hypomania by rapid-rate transcranial magnetic stimulation over the left prefrontal lobe | Q48180725 | ||
| Double-blind controlled investigation of transcranial magnetic stimulation for the treatment of resistant major depression | Q48192263 | ||
| Changes in 5-HT1A and NMDA binding sites by a single rapid transcranial magnetic stimulation procedure in rats | Q48222394 | ||
| ECS-induced dopamine release: effects of electrode placement, anticonvulsant treatment, and stimulus intensity | Q48236211 | ||
| Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study | Q48240509 | ||
| Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. | Q48253921 | ||
| Chronic repetitive transcranial magnetic stimulation alters beta-adrenergic and 5-HT2 receptor characteristics in rat brain | Q48313186 | ||
| High-frequency repetitive transcranial magnetic stimulation delays rapid eye movement sleep | Q48327831 | ||
| Magnetic stimulation of the brain in animal depression models responsive to ECS. | Q48376092 | ||
| Neurochemical effects of electrically and chemically induced seizures: an in vivo microdialysis study in the rat hippocampus | Q48414870 | ||
| Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroxytryptaminergic neurotransmission in the frontal cortex of rats | Q48458364 | ||
| Repetitive transcranial magnetic stimulation (rTMS) in major depression: relation between efficacy and stimulation intensity | Q48469536 | ||
| Physical and Physiological Specification of Magnetic Pulse Stimuli that Produce Cortical Damage in Rats | Q48503641 | ||
| Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients | Q48519678 | ||
| Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial | Q48587129 | ||
| Preliminary comparison of behavioral and biochemical effects of chronic transcranial magnetic stimulation and electroconvulsive shock in the rat. | Q48599181 | ||
| Imaging human intra-cerebral connectivity by PET during TMS. | Q48636075 | ||
| Switch to mania after slow rTMS of the right prefrontal cortex. | Q48643188 | ||
| Sleep deprivation in depression stabilizing antidepressant effects by repetitive transcranial magnetic stimulation | Q48662684 | ||
| Effect of electroconvulsive therapy in repetitive transcranial magnetic stimulation non-responder MDD patients: a preliminary study | Q48681757 | ||
| Effect on the emotions of healthy individuals of slow repetitive transcranial magnetic stimulation applied to the prefrontal cortex | Q48684674 | ||
| Suprathreshold repetitive transcranial magnetic stimulation elevates thyroid-stimulating hormone in healthy male subjects | Q48689870 | ||
| Transcranial magnetic stimulation during positron emission tomography: a new method for studying connectivity of the human cerebral cortex | Q48723856 | ||
| Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study | Q48730872 | ||
| Prefrontal cortex modulation of mood and emotionally induced facial expressions: a transcranial magnetic stimulation study | Q48810802 | ||
| Sub-typing depression, II. Clinical distinction of psychotic depression and non-psychotic melancholia | Q48813517 | ||
| Lack of significant changes on magnetic resonance scans before and after 2 weeks of daily left prefrontal repetitive transcranial magnetic stimulation for depression | Q48906508 | ||
| Modest adjunctive benefit with transcranial magnetic stimulation in medication-resistant depression | Q48907166 | ||
| Transcranial magnetic stimulation-induced switch into mania: a report of two cases | Q48938571 | ||
| Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. | Q48960526 | ||
| Effects of slow rTMS at the right dorsolateral prefrontal cortex on EEG asymmetry and mood | Q48962582 | ||
| Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients | Q49118953 | ||
| Lateralized effect of rapid-rate transcranial magnetic stimulation of the prefrontal cortex on mood | Q49153089 | ||
| Neurobiological effects of extensive transcranial electromagnetic stimulation in an animal model | Q50779558 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 383-403 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | CNS Drugs | Q5013183 |
| P1476 | title | Repetitive transcranial magnetic stimulation : does it have potential in the treatment of depression? | |
| P478 | volume | 17 |
| Q34591323 | Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis |
| Q47843157 | Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression |
| Q37871523 | Clinical trial design in non-invasive brain stimulation psychiatric research. |
| Q51935482 | Critique of the guidelines for the treatment of depression: flaws in the construction. |
| Q38852400 | Low-Dimensional Models of "Neuro-Glio-Vascular Unit" for Describing Neural Dynamics under Normal and Energy-Starved Conditions. |
| Q48390036 | Neural correlates of clinical improvement after deep transcranial magnetic stimulation (DTMS) for treatment-resistant depression: a case report using functional magnetic resonance imaging |
| Q35608399 | Prefrontal cortex stimulation as antidepressant treatment: mode of action and clinical effectiveness of rTMS. |
| Q38554002 | Repetitive transcranial magnetic stimulation (rTMS) for the treatment of depression in Parkinson disease: a meta-analysis of randomized controlled clinical trials |
| Q48095026 | Repetitive transcranial magnetic stimulation does not influence immunological HL-60 cells and neuronal PC12 cells |
| Q44929738 | Repetitive transcranial magnetic stimulation increases the release of dopamine in the nucleus accumbens shell of morphine-sensitized rats during abstinence. |
| Q36827439 | Transcranial and deep brain stimulation approaches as treatment for depression |
| Q35608379 | rTMS as treatment strategy in psychiatric disorders--neurobiological concepts. |
Search more.